Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity
- PMID: 15228445
- DOI: 10.1111/j.1365-2559.2004.01902.x
Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity
Abstract
Aims: Ameloblastoma is an odontogenic neoplasm characterized by local invasiveness and recurrence. In this study we analysed the role played by matrix metalloproteinases (MMPs) in the local invasiveness of ameloblastoma. We also attempted to establish a relationship between the presence of MMPs and the proliferative activity of ameloblastoma cells.
Methods and results: Immunohistochemistry was carried out to detect different MMPs in formalin-fixed paraffin-embedded samples of human ameloblastoma. Immunohistochemistry, however, does not establish whether a given MMP is latent or active. To address this point, we carried out biochemical methods, namely zymography and Western blotting. Our results showed expression of latent and active forms of MMPs 1, 2 and 9 in ameloblastoma. These enzymes may digest bone matrix and release mitogenic factors, which would increase tumour proliferation. This possibility prompted us to study the proliferation of ameloblastoma cells located in close proximity to bone. Silver-stained nucleolar organizer region morphometry revealed that ameloblastoma cells in the vicinity of bone show increased proliferation, when compared with controls.
Conclusions: Our results suggest an interdependent mechanism involving MMPs and proliferation of ameloblastoma cells, which may contribute to the local invasiveness of this tumour.
Similar articles
-
Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour.Histopathology. 2010 Jul;57(1):128-37. doi: 10.1111/j.1365-2559.2010.03596.x. Histopathology. 2010. PMID: 20653784
-
Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity.J Oral Pathol Med. 2009 Oct;38(9):731-6. doi: 10.1111/j.1600-0714.2009.00771.x. Epub 2009 Mar 24. J Oral Pathol Med. 2009. PMID: 19473446
-
Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma.J Oral Pathol Med. 2010 Mar;39(3):242-9. doi: 10.1111/j.1600-0714.2009.00862.x. Epub 2010 Jan 11. J Oral Pathol Med. 2010. PMID: 20070483
-
[Matrix metalloproteinases and colorectal cancer].Med Klin (Munich). 2003 Dec 15;98(12):763-70. doi: 10.1007/s00063-003-1322-5. Med Klin (Munich). 2003. PMID: 14685678 Review. German.
-
Tumour invasion and matrix metalloproteinases.Crit Rev Oncol Hematol. 2004 Mar;49(3):179-86. doi: 10.1016/j.critrevonc.2003.10.008. Crit Rev Oncol Hematol. 2004. PMID: 15036258 Review.
Cited by
-
Association of matrix metalloproteinase 2 and matrix metalloproteinase 9 gene polymorphism in aggressive and nonaggressive odontogenic lesions: A pilot study.J Oral Maxillofac Pathol. 2019 Jan-Apr;23(1):158. doi: 10.4103/jomfp.JOMFP_2_17. J Oral Maxillofac Pathol. 2019. PMID: 31110439 Free PMC article.
-
Presence of myofibroblasts and expression of matrix metalloproteinase-2 (MMP-2) in ameloblastomas correlate with rupture of the osseous cortical.Pathol Oncol Res. 2009 Jun;15(2):231-40. doi: 10.1007/s12253-008-9110-4. Epub 2008 Dec 19. Pathol Oncol Res. 2009. PMID: 19096916
-
Matrix metalloproteinase-9 (mmp-9) expression in different subtypes of ameloblastoma.J Maxillofac Oral Surg. 2014 Sep;13(3):281-5. doi: 10.1007/s12663-013-0538-z. Epub 2013 May 29. J Maxillofac Oral Surg. 2014. PMID: 25018601 Free PMC article.
-
EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence.Diagn Pathol. 2012 Feb 2;7:14. doi: 10.1186/1746-1596-7-14. Diagn Pathol. 2012. PMID: 22300665 Free PMC article.
-
Expression of RECK and matrix metalloproteinase-2 in ameloblastoma.BMC Cancer. 2009 Dec 8;9:427. doi: 10.1186/1471-2407-9-427. BMC Cancer. 2009. PMID: 19995435 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources